Scandinavian Sales Agreement Expands Creso Pharma’s European Footprint
Next Investors
Archived
Mar 04, 2020
Creso Pharma Limited (ASX:CPH, FRA:1X8) has signed a commercial term sheet agreement with Farmagon, Oslo, Norway to enter the Scandinavia market with Creso products.